Key result
Patients with Lewy body disorders had higher galaninergic innervation scores in the nucleus basalis of Meynert compared to age-matched controls.
Case-Control (n=80)
Single-blind
No
Galanin upregulation within the basal forebrain cholinergic system in Lewy body disorders may represent an intrinsic adaptive response to neurodegeneration.
This is the authors' abstract. We don't add key points for this paper.
INTRODUCTION: Depletion of cholinergic neurons within the nucleus basalis of Meynert (nbM) is thought to contribute to the development of cognitive impairments in both Alzheimer's disease (AD) and Lewy body disorders (LBD). It has been reported that, in late stage AD, a network of fibres that contain the neuropeptide galanin displays significant hypertrophy and 'hyperinnervates' the surviving cholinergic neurons. Galanin is considered as a highly inducible neuroprotective factor and in AD this is assumed to be part of a protective tissue response. The aim of this study was to determine if a similar galanin upregulation is present in the nbM in post-mortem tissue from patients with LBD. Gallatin immunohistochemistry was carried out on anterior nbM sections from 76 LBD cases (27 PD, 15 PD with mild cognitive impairment (MCI), 34 PD with dementia (PDD) and 4 aged-matched controls. Galaninergic innervation of cholinergic neurons was assessed on a semi-quantitative scale. RESULTS: The LBD group had significantly higher galaninergic innervation scores (p = 0.016) compared to controls. However, this difference was due to increased innervation density only in a subgroup of LBD cases and this correlated positively with choline acetyltransferase-immunopositive neuron density. CONCLUSION: Galanin upregulation within the basal forebrain cholinergic system in LBD, similar to that seen in AD, may represent an intrinsic adaptive response to neurodegeneration that is consistent with its proposed roles in neurogenesis and neuroprotection.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical management in Lewy body disorders; leaves open mechanistic or biomarker roles pending validation studies.
No takes yet. Share an insight, caveat, or question.
Alexandris et al. (2015) conducted a case-control in Lewy body disorders (n=80). Lewy body disorders vs. Age-matched controls was evaluated on Galaninergic innervation scores in the anterior nucleus basalis of Meynert (p=0.016). Patients with Lewy body disorders had higher galaninergic innervation scores in the nucleus basalis of Meynert compared to age-matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: